A randomized management study of impedance plethysmography vs. contrast venography in patients with a first episode of clinically suspected deep vein thrombosis.

Abstract:

OBJECTIVES:In this randomized management study, we examined the safety of withholding anticoagulation on the basis of negative impedance plethysmography (IPG) compared to negative contrast venography (CV) in symptomatic patients with a first episode of clinically suspected deep vein thrombosis (DVT), and we determined the impact of the limitations of IPG or CV on their clinical utility. METHODS:Patients at a university teaching hospital presenting with a first episode of clinically suspected DVT were randomized to one of two management strategies at study entry: (1) IPG: if positive, confirmatory CV was performed. If CV was positive, anticoagulants were administered, if CV was negative, anticoagulants were held. If negative, IPG was repeated serially and if it remained negative, anticoagulants were held (n = 165). (2) CV: if positive, anticoagulants were administered, if negative, anticoagulants were held (n = 159). The negative predictive value (NPV) of IPG and CV, positive predictive value (PPV) of IPG, and the failure rate of each strategy were assessed. RESULTS:Among IPG patients, 28 of 37 with positive IPG initially or during serial testing and evaluable CV had confirmed DVT (PPV 76%; 95% confidence interval, CI [62%, 90%]). DVT was diagnosed during serial testing in 2.1% of patients with initially negative IPG who completed testing. The NPV overall of negative IPG was 98.3%. During follow-up, two patients in the IPG group (1.2%) and two patients in the CV group (1.3%) developed venous thromboembolism (VTE). Death during follow-up occurred in 11% of IPG patients compared to 6% of CV patients (P =.13) The investigation strategy failed in 25% of IPG patients and in 14% of CV patients. CONCLUSIONS:Our findings demonstrate that the two diagnostic strategies we studied are equivalent methods for ruling out DVT in patients with a first episode of suspected DVT. The PPV of IPG was too low to permit its use alone as a test to rule in DVT. Both strategies had surprisingly high failure rates.

journal_name

Thromb Res

journal_title

Thrombosis research

authors

Kahn SR,Joseph L,Grover SA,Leclerc JR

doi

10.1016/s0049-3848(01)00222-5

subject

Has Abstract

pub_date

2001-04-01 00:00:00

pages

15-24

issue

1

eissn

0049-3848

issn

1879-2472

pii

S0049-3848(01)00222-5

journal_volume

102

pub_type

临床试验,杂志文章,随机对照试验
  • Evidence of a phospholipid binding species within human fibrinogen preparations.

    abstract::Fibrinogen has been reported to interact with phospholipid; however, the properties of this binding interaction have not been characterized. Purified preparations of human fibrinogen bound to small unilamellar vesicles containing phosphatidylserine (PS) as measured by light scattering and radioisotope filtration. Bind...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(99)00058-4

    authors: Cunningham MT,Citron BA,Koerner TA

    更新日期:1999-09-15 00:00:00

  • Thrombin-activatable fibrinolysis inhibitor antigen and TAFI activity in patients with APC resistance caused by factor V Leiden mutation.

    abstract::Thrombin-activatable fibrinolysis inhibitor (TAFI), also known as procarboxypeptidase U or plasma procarboxypeptidase B, is a relatively recently described plasma glycoprotein synthesised in the liver. It can be activated into active enzyme TAFIa (carboxypeptidase U or plasma carboxypeptidase B) by a complex of thromb...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(02)00072-5

    authors: Antovic JP,Blombäck M

    更新日期:2002-04-01 00:00:00

  • Exploring soluble urokinase plasminogen activator receptor and its relationship with arterial stiffness in a bi-ethnic population: the SAfrEIC-study.

    abstract:INTRODUCTION:Elevated soluble urokinase-type plasminogen activator receptor (suPAR) indicates an inflammatory state caused by conditions such as HIV and cancer. Recently suPAR was identified as an indicator of cardiovascular disease (CVD). CVD is highly prevalent in black South Africans, but the potential role of suPAR...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2011.10.034

    authors: Schutte AE,Myburgh A,Olsen MH,Eugen-Olsen J,Schutte R

    更新日期:2012-08-01 00:00:00

  • Turnover of tPA in rabbits: influence of carbohydrate moieties.

    abstract::The turnover of tissue plasminogen activator (tPA) was studied in rabbits using a double-label technique which allowed the comparison of various tPA derivatives with a standard tPA in individual animals. Purified recombinant tPA (Alteplase) was labelled with 125I and used as a standard for each experiment. Various tPA...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(88)90278-2

    authors: Beebe DP,Aronson DL

    更新日期:1988-07-01 00:00:00

  • Abnormally high prevalence of major components of the metabolic syndrome in subjects with early-onset idiopathic venous thromboembolism.

    abstract:BACKGROUND:Although patients with idiopathic VTE are at higher than normal risk of asymptomatic atherosclerosis and of cardiovascular events, the impact of cardiovascular risk factors on VTE is poorly understood. OBJECTIVE:To assess the prevalence of the metabolic syndrome and of its components in patients with early-...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2010.12.005

    authors: Di Minno MN,Tufano A,Guida A,Di Capua M,De Gregorio AM,Cerbone AM,Tarantino G,Di Minno G

    更新日期:2011-03-01 00:00:00

  • The role of thromboxane A2 in increased whole blood platelet aggregation in oral contraceptive users.

    abstract::Epidemiological studies have shown that oral contraceptives increase the risk of thromboembolic disease in susceptible women however the mechanisms involved are unclear. We investigated whole blood platelet aggregation in 44 women randomly allocated to 6 cycles of treatment with either gestodene (75ug) or desogestrel ...

    journal_title:Thrombosis research

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/0049-3848(96)00013-8

    authors: Norris LA,Devitt M,Bonnar J

    更新日期:1996-02-15 00:00:00

  • Arterial thrombosis and cancer.

    abstract::Cancer-associated arterial thrombotic events (ATEs) are increasingly recognized in specific malignancies and in association with the expanding armamentarium of novel chemotherapeutic agents. The improved cancer survival led to cardiovascular complications becoming clinically relevant many years after cancer diagnosis....

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2018.01.003

    authors: Aronson D,Brenner B

    更新日期:2018-04-01 00:00:00

  • Aggregated-disaggregated, refractory platelets retain sensitivity to ristocetin.

    abstract::The present investigation has used an aggregation-disaggregation-reaggregation model to determine if exposure to potent aggregating agents causing a refractory state in deaggregated platelets results in down-regulation and clearance of GPIb/IX, the receptor for von willebrand factor. Thrombin, the thrombin receptor ac...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(96)00185-5

    authors: White JG,Rao GH

    更新日期:1996-11-15 00:00:00

  • Association between red cell distribution width and risk of venous thromboembolism.

    abstract:BACKGROUND:An association between high red cell distribution width (RDW) and venous thromboembolism (VTE) has been observed. However, it is not known whether this association differs within various manifestations of VTE, nor if there is an interaction between RDW and thrombophilia abnormalities on the risk of VTE. AIM...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2015.07.020

    authors: Bucciarelli P,Maino A,Felicetta I,Abbattista M,Passamonti SM,Artoni A,Martinelli I

    更新日期:2015-09-01 00:00:00

  • Low density lipoprotein receptor-related protein (LRP) expression varies among Hep G2 cell lines.

    abstract::The multiligand receptor, low density lipoprotein receptor-related protein (LRP), is implicated in processes such as atherosclerosis and fibrinolysis through its mediation of the catabolism of lipoproteins, proteases, and protease inhibitor complexes. The hepatoma cell line Hep G2 expresses LRP and has been used widel...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(97)00287-9

    authors: Grimsley PG,Quinn KA,Chesterman CN,Owensby DA

    更新日期:1997-12-15 00:00:00

  • Clot waveform analysis in Clauss fibrinogen assay contributes to classification of fibrinogen disorders.

    abstract:BACKGROUND:Clauss fibrinogen assay (CFA) is widely used as a screening test to detect fibrinogen disorders. However, CFA alone cannot distinguish quantitative and qualitative defects because it depends on functional fibrinogen activity (Ac), and fibrinogen antigen (Ag) determination is required to classify fibrinogen d...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2018.12.018

    authors: Suzuki A,Suzuki N,Kanematsu T,Shinohara S,Arai N,Kikuchi R,Matsushita T

    更新日期:2019-02-01 00:00:00

  • Secondary stroke prevention with low-dose aspirin, sustained release dipyridamole alone and in combination. ESPS Investigators. European Stroke Prevention Study.

    abstract::Patients who had survived a stroke or transient ischaemic attacks (TIA) were admitted to a trial of low-dose aspirin (50 mg) alone, sustained release dipyridamole (400 mg/day) alone, or a combination of the two agents, and results compared with a placebo over 24 months. This low-dose aspirin regimen produced in pairwi...

    journal_title:Thrombosis research

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/s0049-3848(98)00099-1

    authors: Forbes CD

    更新日期:1998-09-15 00:00:00

  • Laboratory evaluation of the Coasys® Plus C coagulation analyzer.

    abstract:INTRODUCTION:The Coasys® Plus C (Behnk Elektronik, distributed by Roche Diagnostics) is a coagulation analyzer for small to midsize clinical chemistry laboratories. We performed a laboratory evaluation. MATERIALS AND METHODS:After a familiarization period the dead volume, carry-over, capacity, within-assay reproducibi...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2013.02.004

    authors: de Bie P,Schornagel WJ,van den Dool EJ,Bakker B,van Dam W,Heckman M,Ağar C,Sturk A,Stroobants AK

    更新日期:2013-04-01 00:00:00

  • Modulation of heparin cofactor II activity by glycosaminoglycans and adhesive glycoproteins.

    abstract::Heparin cofactor II (HCII) is a specific thrombin inhibitor; its inhibitory activity is stimulated by heparin (Hep) and dermatan sulfate (DS). Vitronectin (VN), a heparin binding adhesive glycoprotein present in plasma and extracellular matrix, has been shown to decrease the stimulatory effect of Hep but not of DS on ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(92)90310-7

    authors: Petzelbauer E,Seiffert D,Beckmann R,Pusch B,Geiger M,Binder BR

    更新日期:1992-06-01 00:00:00

  • The clock gene Per2 is required for normal platelet formation and function.

    abstract:INTRODUCTION:Apoptotic cell death is a highly regulated genetic program, which has been observed in mature megakaryocytes fragmenting into platelets. The clock gene Per2, a key component of core clock oscillator, was involved in affecting both cell cycle control and apoptosis. Thus, loss of Per2 function may be conside...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2010.11.025

    authors: Zhao Y,Zhang Y,Wang S,Hua Z,Zhang J

    更新日期:2011-02-01 00:00:00

  • Differential localisation and synthesis of porcine factor VIII related antigen (VIIIR:AG) in vascular endothelium and in endothelial cells in culture.

    abstract::Porcine and human umbilical vein and adult blood vessels were studied for the presence and synthesis of factor VIII related antigen (VIIIR:Ag) and fibronectin (Fn) by immunofluorescence histology and immunoautoradiography. Investigation of human tissue confirmed the widespread distribution of VIIIR:Ag on the endotheli...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(83)90042-7

    authors: Giddings JC,Jarvis AL,Bloom AL

    更新日期:1983-02-01 00:00:00

  • Antithrombotic actions of selective inhibitors of blood coagulation factor Xa in rat models of thrombosis.

    abstract::The antithrombotic actions of selective factor Xa (FXa) inhibitors, recombinant tick anticoagulant peptide (rTAP) and DX-9065a, were evaluated in experimental thrombosis models in anesthetized rats. In the first model, thrombosis was induced by exposing flowing blood to a silk thread anchored in an arteriovenous (AV) ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(96)00112-0

    authors: Wong PC,Crain EJ Jr,Nguan O,Watson CA,Racanelli A

    更新日期:1996-07-15 00:00:00

  • Premature arterial and venous events in three families. Effect of folate levels and MTHFR mutation mediated by family/generation and homocysteine levels.

    abstract::Plasma homocysteine levels result from the effect of genetic and environmental factors. We investigated the hypothesis of familial association between folates, methylenetetrahydrofolate reductase (MTHFR) and hyperhomocysteinemia with acute events, studying three families through pedigree analysis and log-linear graphi...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(01)00408-x

    authors: Assanelli D,Grassi M,Bonanome A,Salvadori G,Bonetti P,Boldini A,Archetti S,Ruggeri G,Pezzini A,Pagnan A

    更新日期:2002-01-15 00:00:00

  • Functional characterization of a novel missense mutation, His147Arg, in A1 domain of FV protein causing type II deficiency.

    abstract:INTRODUCTION:Congenital factor V (FV) deficiency is a rare inherited disorder. Three compound heterozygous missense mutations, Asp68His, His147Arg, and Arg2074Cys, were observed in a Taiwanese patient with moderately severe FV deficiency. METHOD:The novel His147Arg mutation in the A1 domain was investigated by protein...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2014.04.005

    authors: Liu HC,Lin TM,Eng HL,Lin YT,Shen MC

    更新日期:2014-07-01 00:00:00

  • AD6 (8-monochloro-3-beta-diethylamino-ethyl-4-methyl-7-ethoxycarbonyl-meth oxy coumarin) inhibits the release of arachidonic acid in human platelets stimulated by thrombin.

    abstract::The coumarin derivative AD6 is known to inhibit platelet aggregation and release and it possesses vasodilatory properties on coronary arteries of laboratory animals. Furthermore, the inhibition of the production of TxB2 from endogenous substrates after stimulation of human platelets with collagen has been demonstrated...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(87)90236-2

    authors: Porcellati S,Costantini V,Prosdocimi M,Pistolesi R,Porrovecchio P,Nenci GG,Goracci G

    更新日期:1987-07-01 00:00:00

  • Subcutaneous treatment of deep venous thrombosis with low molecular weight heparin. A dose finding study with LMWH-Novo.

    abstract::Treatment of deep venous thrombosis with low molecular weight heparin (LMWH-Novo, Logiparin) was carried out with two different doses of Logiparin, 75 XaI U/kg b.w. twice daily and 150 XaI U/kg b.w. once daily subcutaneously for 5 days. Simultaneously warfarin was given from the first day of heparin treatment. Mean ag...

    journal_title:Thrombosis research

    pub_type: 临床试验,杂志文章

    doi:10.1016/0049-3848(89)90307-1

    authors: Siegbahn A,Y-Hassan S,Boberg J,Bylund H,Neerstrand HS,Ostergaard P,Hedner U

    更新日期:1989-09-15 00:00:00

  • Protease action and generation of beta-thromboglobulin-like protein followed by platelet activation.

    abstract::Beta-thromboglobulin (beta-TG) is a platelet-specific protein present in the alpha-granules and secreted into the surrounding medium on cell activation. The sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) of platelet releasate after inhibition of metalloproteinases with ethyleneglycol-bis-(beta-a...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(02)00135-4

    authors: Resmi KR,Krishnan LK

    更新日期:2002-05-15 00:00:00

  • Chylothorax in children with congenital heart disease: incidence of thrombosis.

    abstract::Postoperative chylothorax is a frequently encountered pathology occurring in up to 4% of patients undergoing surgery for repair of congenital heart disease. Symptomatic thrombosis is associated with chylothorax and may contribute to its severity and duration. Furthermore, vessel thrombosis resulting in persistent vess...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2013.06.014

    authors: Bauman ME,Moher C,Bruce AK,Kuhle S,Kaur S,Massicotte MP

    更新日期:2013-08-01 00:00:00

  • Monoclonal antibodies against plasminogen and alpha-2-antiplasmin: binding to native and modified antigens.

    abstract::Two monoclonal antibodies against plasminogen and two against alpha-2-antiplasmin were characterized regarding their binding properties towards their respective native and modified antigens and towards the plasmin-alpha-2-antiplasmin complex. Using an ELISA system, the two monoclonal antibodies against plasminogen (MP...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(87)90311-2

    authors: Hattey E,Wojta J,Binder BR

    更新日期:1987-03-01 00:00:00

  • Comparison of methods for detecting soluble fibrin in plasma. An in vitro study.

    abstract::The ability of the COA-SET Fibrin monomer (COA-SET FM) test to detect soluble fibrin was evaluated by comparing the results of the COA-SET FM test with fibrinopeptide A (FPA) determinations following thrombin incubation of plasma or whole blood. In addition, two semiquantitative tests (erythrocytes-agglutination test ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(90)90066-l

    authors: Halvorsen S,Skjønsberg OH,Ruyter R,Godal HC

    更新日期:1990-02-15 00:00:00

  • Incidence and risk factors of subclinical umbilical catheter-related thrombosis in neonates.

    abstract:INTRODUCTION:This study aimed to determine the risk factors for subclinical umbilical catheter-related thrombosis (UCRT) and its association with clinical morbidities. MATERIALS AND METHODS:In infants without any symptoms associated with umbilical catheterization, the presence of thrombosis was monitored using abdomin...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2020.05.034

    authors: Hwang JH,Chung ML,Lim YJ

    更新日期:2020-10-01 00:00:00

  • Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent.

    abstract:OBJECTIVES:This study examines whether patient resistance to clopidogrel is associated with long-term thrombotic events after elective coronary drug-eluting stent (DES) implantation. METHODS:We prospectively enrolled 386 patients with stable angina who received elective percutaneous coronary intervention (PCI) with DE...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2008.10.007

    authors: Wang ZJ,Zhou YJ,Liu YY,Yu M,Shi DM,Zhao YX,Guo YH,Cheng WJ,Jia de A,Cao Z,Nie B,Ge HL,Yang SW,Yan ZX

    更新日期:2009-05-01 00:00:00

  • Protective activity of defibrotide against lethal acute myocardial ischemia in the cat.

    abstract::Defibrotide (D) is a natural polydeoxyribonucleotide from mammalian lungs with profibrinolytic and antithrombotic activities. D also has PGI2-stimulating and tissue plasminogen activator (TPA)-releasing activities, but has no anticoagulant properties. The protective effects of D were demonstrated very recently in a mo...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(86)90265-3

    authors: Niada R,Porta R,Pescador R,Mantovani M,Prino G

    更新日期:1986-05-01 00:00:00

  • To screen or not to screen for chronic thromboembolic pulmonary hypertension after acute pulmonary embolism.

    abstract::Chronic thromboembolic pulmonary hypertension (CTEPH) is the most severe long term complication of acute pulmonary embolism (PE). Untreated, CTEPH is associated with a very poor prognosis and high risk of mortality, although curation can be achieved by surgical removal of the obstructive endothelialised thromboemboli ...

    journal_title:Thrombosis research

    pub_type: 杂志文章,评审

    doi:10.1016/j.thromres.2016.12.026

    authors: Ende-Verhaar YM,Huisman MV,Klok FA

    更新日期:2017-03-01 00:00:00

  • Effects of exercise test on plasma markers of an activation of coagulation and/or fibrinolysis in patients with symptomatic or silent myocardial ischemia.

    abstract::It has been suggested that unstable angina at rest, like acute myocardial infarction, might be associated with a thrombotic process. In order to study the hypothesis that myocardial ischemia during exercise could also be associated with an activation of blood coagulation and/or fibrinolysis, we investigated the presen...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(92)90222-v

    authors: Bounameaux H,Righetti A,de Moerloose P,Bongard O,Reber G

    更新日期:1992-01-01 00:00:00